Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Douglas Loe report not on tipranks yet
View:
Post by askretka on May 12, 2021 9:32am

Douglas Loe report not on tipranks yet

Not sure how much effect it will have but it's not widely available yet. It's my goto report for this stock. Price is a disappointment but like I said I've seen this all before. As Warren Buffet once said. The stock market is a way of transferring wealth from the impatient to the patient but I agree this one has tried everyone's patience. I stll feel this is an amazing investment opportunity. Cheers!
Comment by JohnnyYeg on May 12, 2021 10:20am
I get what you say about patience, and I know for some it is beyond trying. But I know what we have here, and the process a biotech has to go through, and the trials when new information is uncovered that affects MOA and research. This stock will change my life, so if I have to wait another year or two, so be it. My entire focus with ONC is the end game of Pelareorep.
Oncolytics Biotech Inc